|
|
||||||||
From the Division of Neuropathology (Drs. Parchi, Capellari, and Gambetti), Institute of Pathology, Case Western Reserve University, Cleveland, OH; Department of Pathology (Dr. Chin), College of Physicians and Surgeons of Columbia University, New York, NY; Departments of Neurology (Drs. Schwarz and Powers) and Pathology (Dr. Powers), University of Rochester Medical Center, Rochester, NY; Wake Medical Center (Dr. Schecter), Raleigh, NC; Division of Epidemiology (Dr. Butts), North Carolina Department of Health and Human Services, Chapel Hill, NC; Department of Pathology (Dr. Hudkins), United Regional Health Care System, Wichita Falls, TX; and Department of Pathology (Dr. Burns), University of Southwest Texas Medical Center, Dallas, TX.
Address correspondence and reprint requests to Dr. Pierluigi Gambetti, Division of Neuropathology, Institute of Pathology, Case Western Reserve University, 2085 Adelbert Road, Cleveland, OH 44106.
Article Abstract
OBJECTIVE: To establish a variant of sporadic prion disease as the sporadic form of fatal familial insomnia (FFI).
BACKGROUND: FFI is a recently described prion disease characterized clinically by severe sleep impairment, dysautonomia, and motor signs, and pathologically by atrophy of thalamic nuclei, especially the medial dorsal and anterior ventral, and of the inferior olive. FFI is linked to the D178N mutation coupled with the methionine codon at position 129 in the prion protein gene (PRNP). It is also identified by the properties of the abnormal prion protein (PrPSc), which has the relative molecular mass of 19 kDa, corresponding to the so-called type 2, and a marked underrepresentation of the unglycosylated form relative to the diglycosylated and monoglycosylated forms.
METHODS: Clinical, pathologic, PrPSc, and PRNP data from 5 subjects with a sporadic prion disease phenotypically similar to FFI were collected and analyzed.
RESULTS: All 5 subjects had a disease clinically similar and histopathologically virtually identical to FFI. PrPSc type 2 was present in all subjects in amount and distribution similar to those of FFI. However, the PrPSc did not show the striking underrepresentation of the unglycosylated isoform of the protein that is characteristic of FFI. Moreover, none of the subjects had the D178N PRNP mutation but all were homozygous for methionine at codon 129.
CONCLUSION: This condition is likely to represent the sporadic form of FFI and the term "sporadic fatal insomnia" is proposed.
This article has been cited by other articles:
![]() |
L. R. Mehta, B. J. Huddleston, E. J. Skalabrin, J. B. Burns, W.-Q. Zou, P. Gambetti, and S. S. Chin Sporadic Fatal Insomnia Masquerading as a Paraneoplastic Cerebellar Syndrome Arch Neurol, July 1, 2008; 65(7): 971 - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cortelli, D. Perani, P. Montagna, R. Gallassi, P. Tinuper, P. Federica, P. Avoni, F. Ferrillo, D. Anchisi, R. M. Moresco, et al. Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies Brain, March 1, 2006; 129(3): 668 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pastore, S. S. Chin, K. L. Bell, Z. Dong, Q. Yang, L. Yang, J. Yuan, S. G. Chen, P. Gambetti, and W.-Q. Zou Creutzfeldt-Jakob Disease (CJD) with a Mutation at Codon 148 of Prion Protein Gene: Relationship with Sporadic CJD Am. J. Pathol., December 1, 2005; 167(6): 1729 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hamaguchi, T. Kitamoto, T. Sato, H. Mizusawa, Y. Nakamura, M. Noguchi, Y. Furukawa, C. Ishida, I. Kuji, K. Mitani, et al. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease Neurology, February 22, 2005; 64(4): 643 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kikuchi, T. Kakeya, A. Sakai, K. Takatori, N. Nakamura, H. Matsuda, T. Yamazaki, K.-i. Tanamoto, and J.-i. Sawada Propagation of a protease-resistant form of prion protein in long-term cultured human glioblastoma cell line T98G J. Gen. Virol., November 1, 2004; 85(11): 3449 - 3457. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Huang, S. K. Marie, J. A. Livramento, R. Chammas, and R. Nitrini 14-3-3 protein in the CSF of patients with rapidly progressive dementia Neurology, August 12, 2003; 61(3): 354 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gambetti, Q. Kong, W. Zou, P. Parchi, and S. G Chen Sporadic and familial CJD: classification and characterisation Br. Med. Bull., June 1, 2003; 66(1): 213 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Cibula, S. Eisenschenk, M. Gold, T. A. Eskin, R. L. Gilmore, and K. M. Heilman Progressive Dementia and Hypersomnolence With Dream-Enacting Behavior: Oneiric Dementia Arch Neurol, April 1, 2002; 59(4): 630 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Taratuto, P. Piccardo, E. G. Reich, S. G. Chen, G. Sevlever, M. Schultz, A. A. Luzzi, M. Rugiero, G. Abecasis, M. Endelman, et al. Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease Neurology, February 12, 2002; 58(3): 362 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Korth, K. Kaneko, and S. B. Prusiner Expression of unglycosylated mutated prion protein facilitates PrPSc formation in neuroblastoma cells infected with different prion strains J. Gen. Virol., October 1, 2000; 81(10): 2555 - 2563. [Abstract] [Full Text] |
||||
![]() |
C Tabernero, J M Polo, M D Sevillano, R Munoz, J Berciano, A Cabello, B Baez, J R Ricoy, R Carpizo, J Figols, et al. Fatal familial insomnia: clinical, neuropathological, and genetic description of a Spanish family J. Neurol. Neurosurg. Psychiatry, June 1, 2000; 68(6): 774 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Scott, R. Will, J. Ironside, H.-O. B. Nguyen, P. Tremblay, S. J. DeArmond, and S. B. Prusiner From the Cover: Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans PNAS, December 21, 1999; 96(26): 15137 - 15142. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pan, M. Colucci, B.-S. Wong, R. Li, T. Liu, R. B. Petersen, S. Chen, P. Gambetti, and M.-S. Sy Novel Differences between Two Human Prion Strains Revealed by Two-dimensional Gel Electrophoresis J. Biol. Chem., September 28, 2001; 276(40): 37284 - 37288. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |